LI vs SABSW · P/E 24, rev $16.06B vs P/E 0.0
Li Auto Inc (LI) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
SABSW does not have a complete income-statement cache yet.
LI currently screens at market cap $26.62B and trailing P/E 24.2. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the LI and SABSW stock pages for the full models.
Not investment advice.